Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Tanner

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Neurology|March 23, 2005
Consumption of milk and calcium in midlife and the future risk of Parkinson diseaseM Park, G W Ross, H Petrovitch, et al.
Neurology|August 15, 2001
Frequency of bowel movements and the future risk of Parkinson's diseaseR D Abbott, H Petrovitch, L R White, et al.
Neurology|October 9, 2002
Midlife adiposity and the future risk of Parkinson's diseaseR D Abbott, G W Ross, L R White, et al.
Neurology|February 1, 1990
Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor dataC G Goetz, C M Tanner, R D Penn, et al.
Neurology|November 4, 2006
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030E R Dorsey, R Constantinescu, J P Thompson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 15, 2005
The North American Multiple System Atrophy Study GroupS Gilman, S J May, C W Shults, et al.
NPJ Parkinson'S Disease|July 14, 2018
Prevalence of Parkinson's disease across North AmericaC Marras, J C Beck, J H Bower, et al.
Neurology|August 19, 2007
Minimum incidence of primary cervical dystonia in a multiethnic health care populationC Marras, S K Van den Eeden, R D Fross, et al.
JAMA|May 20, 2000
Association of coffee and caffeine intake with the risk of Parkinson diseaseG W Ross, R D Abbott, H Petrovitch, et al.
European Journal of Neurology|February 2, 2011
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's diseaseR A Popat, S K Van Den Eeden, C M Tanner, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Neurology|March 23, 2005
Consumption of milk and calcium in midlife and the future risk of Parkinson diseaseM Park, G W Ross, H Petrovitch, et al.
Neurology|August 15, 2001
Frequency of bowel movements and the future risk of Parkinson's diseaseR D Abbott, H Petrovitch, L R White, et al.
Neurology|October 9, 2002
Midlife adiposity and the future risk of Parkinson's diseaseR D Abbott, G W Ross, L R White, et al.
Neurology|February 1, 1990
Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor dataC G Goetz, C M Tanner, R D Penn, et al.
Neurology|November 4, 2006
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030E R Dorsey, R Constantinescu, J P Thompson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 15, 2005
The North American Multiple System Atrophy Study GroupS Gilman, S J May, C W Shults, et al.
NPJ Parkinson'S Disease|July 14, 2018
Prevalence of Parkinson's disease across North AmericaC Marras, J C Beck, J H Bower, et al.
Neurology|August 19, 2007
Minimum incidence of primary cervical dystonia in a multiethnic health care populationC Marras, S K Van den Eeden, R D Fross, et al.
JAMA|May 20, 2000
Association of coffee and caffeine intake with the risk of Parkinson diseaseG W Ross, R D Abbott, H Petrovitch, et al.
European Journal of Neurology|February 2, 2011
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's diseaseR A Popat, S K Van Den Eeden, C M Tanner, et al.
Pageof 14